Chemist Warehouse's $9 billion ASX listing through Sigma Healthcare

This chapter discusses the $9 billion reverse takeover of Chemist Warehouse by Sigma Healthcare, which will result in Chemist Warehouse being listed on the ASX. It explores the history and growth of Chemist Warehouse, the potential benefits of an IPO, and the uncertainties and secrets surrounding a listed company. It also examines the role of David DePillar in driving the deal between HMC Capital and Sigma, and how his innovative approach solved the problem of listing a large company on the ASX without an IPO.